Sjs Investment Consulting Inc. Bristol Myers Squibb CO Transaction History
Sjs Investment Consulting Inc.
- $499 Million
- Q2 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 830 shares of BMY stock, worth $40,421. This represents 0.01% of its overall portfolio holdings.
Number of Shares
830
Previous 852
2.58%
Holding current value
$40,421
Previous $46,000
26.09%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...